Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab

Product News   May 24, 2018

 
Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab

Bio-Rad Anti-idiotypic Antibodies

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology

Product News

New library preparation solution for targeted next-generation sequencing is first to combine gene panel design customization with ultra-high sensitivity.

READ MORE

Agile Sciences-Breaking the Cycle of Antibiotic Resistance

Product News

The alarming and growing cases of antibiotic resistant bacteria and the diminishing number of effective antibiotics to fight infections is a well-documented global health concern and also a potential national security issue.

READ MORE

Clinigen Signs Exclusive Supply & Distribution Agreement with Lukare for Elliotts B® Solution

Product News

Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has signed an exclusive agreement with Lukare Medical (‘Lukare’) to manage the supply and distribution of Elliotts B® Solution.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy